Skip to content
healthcare.dev

Atovaquone Oral Suspension

NDC 10702-223, Atovaquone, suspension, from KVK-Tech, Inc..

Product NDC
10702-223
Status
Listed
Labeler
KVK-Tech, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10702-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
10702-223-21107020223211 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b31ff20a-c363-4be0-9bc0-3081c163b63c
  • NADAC price for package 10702022321

    GET /v1/drugs/nadac/10702022321

Use it

Look up 10702-223 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10702-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10702-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.